- Global health company Ada has recorded significant growth
in the last 8 months, signing multiple new partnerships around the
world
- New partners include key players across life sciences,
insurance, health systems and global development - including AXA
OneHealth, Santéclair, Novartis, CUF, TAJ Digital Health and Sutter
Health
BERLIN, LONDON and
NEW YORK, June 15, 2021 /PRNewswire/ -- Ada, the global
health company, has recorded significant growth in the last 8
months, signing more than 10 new partnerships with key global
players across life sciences, insurance and health systems. A
number of further partnerships are in development.
The last year has seen a tipping point for the adoption of
AI-powered solutions in healthcare, as organizations and users
across the ecosystem have looked for innovative solutions to major
healthcare challenges - including the Covid-19 pandemic, as well as
the longer term pressures of growing and aging populations and
rising health inequality globally. Trustworthy digital solutions
that provide value, have a high degree of medical quality and can
be deployed within organizations' existing ecosystems efficiently,
safely and effectively are in high demand. Multiple innovative
organizations have recently chosen Ada as their partner to
transform patient experiences, leveraging Ada's enterprise
solutions to support in the delivery of healthcare goals.
Offering exceptional medical safety and accuracy, Ada's
AI-driven enterprise solutions are based on the same technology,
medical knowledge and user experience that helped Ada's consumer
symptom assessment app become the world's most popular and highest
rated. Having been made available to partners in 2020, Ada's
enterprise solutions are designed to help organizations deliver
better care experiences and connect clinical journeys, helping
improve user outcomes while driving up efficiency and user
satisfaction.
With Ada's enterprise solutions, partners have access to Ada's
industry-leading AI-based symptom assessment and care navigation,
which helps users to understand their symptoms, identify likely
conditions and navigate to appropriate care. By using Ada as a
'digital front door' to care, partners can help users navigate
quickly and easily to the right care at the right time, while
freeing up precious time and resources for their team. Ada also
offers optional embedded appointment booking, single sign on
features, integration into the partner's electronic patient record
and advanced data insights, giving every partner the ability to
tailor the integration to their organization's specific needs.
Ada partners with organizations across a range of industries,
including:
- Insurance:
-
- For health insurers, Ada transforms users' health journeys,
helping providers to connect users with the appropriate partners
within their ecosystem faster and more efficiently.
- New partners include Santéclair, a leading French service
provider that works with over 50 insurers and healthcare providers
to facilitate access to specialist services such as dentists,
dieticians or opticians, and AXA OneHealth, the Egypt-based subsidiary of global insurance and
healthcare leader, AXA.
- Health Systems:
-
- Ada supports major health systems in the delivery of quality,
efficient and value-based care, improving processes and saving
valuable time and resources for their teams.
- Recent partnerships include the private health system CUF in
Portugal, private business group
Obeikan Digital Solutions in Saudi
Arabia to include Ada in their telemedicine subsidiary TAJ
Digital Health's services, as well as a longer term collaboration
with leading health provider Sutter Health in the United States.
- Life Sciences:
-
- Ada works with life science organizations to raise awareness
for difficult to diagnose and rare diseases, supporting accurate
and timely diagnosis, and empowering people to better understand
their conditions and care options.
- Ada builds on existing collaborations with global life science
leaders such as Pfizer, Takeda, and Novartis in rare diseases, and
has recently signed a new global partnership with Novartis focused
on improving the identification and diagnosis of a number of
immunologic and rare diseases, as well as a new partnership with
Takeda to improve identification and diagnosis of adult and
pediatric attention deficit disorders. Additional new partnerships
include collaborations with Alnylam and SanofiGenzyme.
Commentary:
Daniel Nathrath, CEO & Co-Founder of Ada
said:
"We founded Ada ten years ago because we believed that AI would
fundamentally transform healthcare. Today, we are seeing that
vision become a reality as organizations across all areas of
healthcare turn to AI-powered solutions to help them tackle the
unprecedented challenges facing society; from the unique
circumstances of Covid-19 to the long-term pressures created by
growing and aging populations.
However, we are still just at the beginning of this story. At
Ada, we believe that many of the benefits of health AI can only be
unlocked through cross-industry collaboration, which is why we are
focused on working with industry leading partners from across all
areas of healthcare. We are proud to have signed more than 10 new
partners globally in the last 8 months, with more in advanced
negotiations, and we look forward to working closely with
innovators across life sciences, insurance, health systems and
global development as we continue our mission to transform the
future of healthcare, and improve health experiences and outcomes
for everyone."
Marianne Binst, CEO of
Santéclair, said:
"One of our primary reasons for choosing to partner with Ada was
the ability to integrate its solution into Santéclair's unique
model. Combined, these two solutions enable us to offer our
customers a truly unique service, one unlike anything else on the
market in the region, enabling as many as 10 million users across
France to benefit from a service
that has been tested by Santéclair's Health Innovation Lab.
The medical quality, algorithm efficiency and user experience of
the Ada platform were all key factors when it came to selecting the
right solution. With Ada, we saw the same commitment to high
standards that we guarantee to our customers; this is a core shared
value, and one which will help enable us to further our strategic
ambition as an innovative company with the Mysantéclair digital
platform."
About Ada
Ada is a global health company founded by doctors, scientists
and industry pioneers to create new possibilities for personal
health, and transform knowledge into better outcomes. Its core
system connects medical knowledge with intelligent technology to
help all people actively manage their health and medical
professionals to deliver effective care, and the company works with
leading health providers, organizations and governments to carry
out this vision. The Ada platform has 11 million users worldwide,
and has completed 23 million assessments since its global launch in
2016.
In May 2021, Ada raised
$90 million in a Series B investment
round led by Leaps by Bayer, the impact investment arm of Bayer AG,
with participation from the likes of Samsung Catalyst Fund,
Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.
To learn more, visit www.ada.com.
Contact:
ada@thisisoutcast.com